期刊文献+

Red cell distribution width in anemic patients undergoing transcatheter aortic valve implantation

Red cell distribution width in anemic patients undergoing transcatheter aortic valve implantation
下载PDF
导出
摘要 AIM: To determine the impact of red blood cell distribution width on outcome in anemic patients undergoing transcatheter aortic valve implantation(TAVI).METHODS: In a retrospective single center cohort study we determined the impact of baseline red cell distribution width(RDW) and anemia on outcome in 376 patients with aortic stenosis undergoing TAVI. All patients were discussed in the institutional heart team and declined for surgical aortic valve replacement due to high operative risk. Collected data included patient characteristics, imaging findings, periprocedural in hospital data, laboratory results and follow up data. Blood samples for hematology and biochemistry analysis were taken from every patient before and at fixed intervals up to 72 h after TAVI including blood count and creatinine. Descriptive statistics were used for patient's characteristics. KaplanMeier survival curves were used for time to event outcomes. A recursive partitioning regression and classification was used to investigate the association between potential risk factors and outcome variables.RESULTS: Mean age in our study population was 81 ± 6.1 years. Anemia was prevalent in 63.6%(n = 239) of our patients. Age and creatinine were identified as risk factors for anemia. In our study population, anemia per se did influence 30-d mortality but did not predict longterm mortality. In contrast, a RDW > 14% showed to be highly predictable for a reduced short- and longterm survival in patients with aortic valve disease after TAVI procedure.CONCLUSION: Age and kidney function determine the degree of anemia. The anisocytosis of red blood cells in anemic patients supplements prognostic information in addition to that derived from the WHO-based definition of anemia. AIM: To determine the impact of red blood cell distribution width on outcome in anemic patients undergoing transcatheter aortic valve implantation (TAVI).METHODS: In a retrospective single center cohort study we determined the impact of baseline red cell distribution width (RDW) and anemia on outcome in 376 patients with aortic stenosis undergoing TAVI. All patients were discussed in the institutional heart team and declined for surgical aortic valve replacement due to high operative risk. Collected data included patient characteristics, imaging findings, periprocedural in hospital data, laboratory results and follow up data. Blood samples for hematology and biochemistry analysis were taken from every patient before and at fixed intervals up to 72 h after TAVI including blood count and creatinine. Descriptive statistics were used for patient’s characteristics. Kaplan-Meier survival curves were used for time to event outcomes. A recursive partitioning regression and classification was used to investigate the association between potential risk factors and outcome variables.RESULTS: Mean age in our study population was 81 ± 6.1 years. Anemia was prevalent in 63.6% (n = 239) of our patients. Age and creatinine were identified as risk factors for anemia. In our study population, anemia per se did influence 30-d mortality but did not predict longterm mortality. In contrast, a RDW > 14% showed to be highly predictable for a reduced short- and longterm survival in patients with aortic valve disease after TAVI procedure.CONCLUSION: Age and kidney function determine the degree of anemia. The anisocytosis of red blood cells in anemic patients supplements prognostic information in addition to that derived from the WHO-based definition of anemia.
出处 《World Journal of Cardiology》 CAS 2016年第2期220-230,共11页 世界心脏病学杂志(英文版)(电子版)
关键词 ANEMIA RED cell distribution width RED blood cells TRANSCATHETER AORTIC valve implantation AORTIC STENOSIS Anemia Red cell distribution width Red blood cells Transcatheter aortic valve implantation Aortic stenosis
  • 相关文献

参考文献38

  • 1Alexander Kulier,Jack Levin,Rita Moser,Gudrun Rumpold-Seitlinger,Iulia Cristina Tudor,Stephanie A. Snyder-Ramos,Patrick Moehnle,Dennis T. Mangano.??Impact of Preoperative Anemia on Outcome in Patients Undergoing Coronary Artery Bypass Graft Surgery(J)Circulation . 2007 (5)
  • 2Torsten Hothorn,Kurt Hornik,Achim Zeileis.??Unbiased Recursive Partitioning: A Conditional Inference Framework(J)Journal of Computational and Graphical Statistics . 2006 (3)
  • 3CHRISTIAN RAINER,DAVID T. KAWANISHI,P. ANTHONY N. CHANDRARATNA,RUPERT M. BAUERSACHS,CHERYL L. REID,SHAHBUDIN H. RAHIMTOOLA,HERBERT J. MEISELMAN.??Changes in blood rheology in patients with stable angina pectoris as a result of coronary artery disease(J)Circulation . 1987 (1)
  • 4G. Michael Felker,Larry A. Allen,Stuart J. Pocock,Linda K. Shaw,John J.V. McMurray,Marc A. Pfeffer,Karl Swedberg,Duolao Wang,Salim Yusuf,Eric L. Michelson,Christopher B. Granger.??Red Cell Distribution Width as a Novel Prognostic Marker in Heart Failure(J)Journal of the American College of Cardiology . 2007 (1)
  • 5Lutz HU,Bogdanova A.Mechanisms tagging senescent red blood cells for clearance in healthy humans. Front Physiol . 2013
  • 6Shavit L,Hitti S,Silberman S,Tauber R,Merin O,Lifschitz M,Slotki I,Bitran D,Fink D.Preoperative hemoglobin and outcomes in patients with CKD undergoing cardiac surgery. Clin J Am Soc Nephrol . 2014
  • 7Vahanian A,Alfieri O,Andreotti F,Antunes MJ,Baron-Esquivias G,Baumgartner H,Borger MA,Carrel TP,De Bonis M,Evangelista A,Falk V,Iung B,Lancellotti P,Pierard L,Price S,Schafers HJ,Schuler G,Stepinska J,Swedberg K,Takkenberg J,Von Oppell UO,Windecker S,Zamo.(Guidelines on the management of valvular heart disease(version 2012).The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology(ESC)and the European Association for Cardio-Thoracic Surgery(EACTS))G Ital Cardiol(Rome) . 2013
  • 8Kappetein AP,Head SJ,Généreux P,Piazza N,van Mieghem NM,Blackstone EH,Brott TG,Cohen DJ,Cutlip DE,van Es GA,Hahn RT,Kirtane AJ,Krucoff MW,Kodali S,Mack MJ,Mehran R,RodésCabau J,Vranckx P,Webb JG,Windecker S,Serruys PW,Leon MB.Updated standardized endpoint definitions for transcatheter aortic valve implantation:the Valve Academic Research Consortium-2consensus document. Journal of Thoracic and Cardiovascular Surgery . 2013
  • 9Nikolsky E,Mehran R,Sadeghi HM,Grines CL,Cox DA,Garcia E,Tcheng JE,Griffin JJ,Guagliumi G,Stuckey T,Turco M,Fahy M,Lansky AJ,Stone GW.Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction:analysis from the CADILLAC(Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications)Trial. JACC Cardiovasc Interv . 2009
  • 10Nuis RJ,Sinning JM,Rodés-Cabau J,Gotzmann M,van Garsse L,Kefer J,Bosmans J,Yong G,Dager AE,Revilla-Orodea A,Urena M,Nickenig G,Werner N,Maessen J,Astarci P,Perez S,Benitez LM,Amat-Santos IJ,López J,Dumont E,van Mieghem N,van Gelder T,van Domburg RT,de J.Prevalence,factors associated with,and prognostic effects of preoperative anemia on short-and long-term mortality in patients undergoing transcatheter aortic valve implantation. Circ Cardiovasc Interv . 2013

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部